Table 5.
Baseline, procedural, and clinical differences between patients deceased versus alive at the time of discharge
| Died during index hospitalization (n=6) | Alive at discharge (n=15) | |
|---|---|---|
| Male gender | 4 (67%) | 14 (93%) |
| Age | 69 [52–72.5] | 67 [49.5–68] |
| LVEF | 19 [15.75–20] | 30 [17–35] |
| PAINESD score | 20.5 [15–23] | 17 [14–20] |
| Clinical VT non-inducible* | 2/4 (50%) | 6 (60%) |
| ICM | 5 (83%) | 13 (87%) |
| NICM | 1 (17%) | 3 (20%) |
| Prior VT ablation | 2 (33%) | 5 (33%) |
| Number of home AADs | 1 [0.25–1] | 0 [0–1] |
| Duration in cardiogenic shock prior to procedure (days) | 9 [5.25–12.75] | 4 [1.5–6.5] |
| Duration in cardiogenic shock after to procedure (days) | 9 [3.5–10.75] | 3 [1–4.5] |
| Total duration in cardiogenic shock (days) | 13 [11.25–21.5] | 8 [4.5–9.5] |
In patients with baseline inducible ventricular tachycardia